The quadrivalent HPV vaccine, developed by multinational pharmaceutical company Merck, was approved on Jan 8 for males on the Chinese mainland. The vaccine targets HPV types 6, 11, 16 and 18. The ...
Non-persistent human papillomavirus (HPV) infections are characterized by a sharp increase in viral load followed by a long plateau, according to a study published January 21st in the open-access ...
Dynamics of HPV virus load over the course of an acute infection. The diagram represents variations in the mean number of viruses per cell in the samples over time. The dark band shows the median ...
HPV, the human papilloma virus, is extremely common, with Cancer Research UK suggesting that around 80% of people will experience it during their lifetime. But in the run-up to Cervical Cancer ...